These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32404686)

  • 21. [Varicella-zoster-immunoglobulin as a safe prophylaxis of varicella (author's transl)].
    Kornhuber B; Kropp H; Ribeiro-Ayeh J; Hinderfeld L; Welte K
    Monatsschr Kinderheilkd; 1982 Jan; 130(1):27-9. PubMed ID: 6278297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination against varicella as post-exposure prophylaxis in adults: a quantitative assessment.
    Souty C; Boos E; Turbelin C; Blanchon T; Hanslik T; Boëlle PY
    Vaccine; 2015 Jan; 33(3):446-50. PubMed ID: 25475956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outbreak of varicella at a day-care center despite vaccination.
    Galil K; Lee B; Strine T; Carraher C; Baughman AL; Eaton M; Montero J; Seward J
    N Engl J Med; 2002 Dec; 347(24):1909-15. PubMed ID: 12477940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents.
    Clements DA; Armstrong CB; Ursano AM; Moggio MM; Walter EB; Wilfert CM
    Pediatr Infect Dis J; 1995 Oct; 14(10):874-9. PubMed ID: 8584315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands.
    Pierik JG; Gumbs PD; Fortanier SA; Van Steenwijk PC; Postma MJ
    BMC Infect Dis; 2012 May; 12():110. PubMed ID: 22574722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation on sera prevalence rate of varicella and immunogenicity of varicella vaccine in healthy children].
    Zhou T; Wang J; Qiu P
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Oct; 19(5):271-3. PubMed ID: 10322684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outbreak of varicella in preschool children despite one-dose vaccination.
    Kurugöl Z; Gökçe Ş
    Turk J Pediatr; 2018; 60(1):56-62. PubMed ID: 30102480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroepidemiology of varicella in children from Spain.
    Cilla Eguiluz G; Perez Trallero E; García Arenzana JM
    J Infect Dis; 1987 Nov; 156(5):851. PubMed ID: 2821130
    [No Abstract]   [Full Text] [Related]  

  • 29. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.
    Poletti P; Melegaro A; Ajelli M; Del Fava E; Guzzetta G; Faustini L; Scalia Tomba G; Lopalco P; Rizzo C; Merler S; Manfredi P
    PLoS One; 2013; 8(4):e60732. PubMed ID: 23613740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient.
    Bernstein P; Furuya Y; Steinberg S; Scully B; Larussa P; Gershon AA
    Am J Infect Control; 2011 Apr; 39(3):247-9. PubMed ID: 21269735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of second-dose varicella vaccination as post-exposure prophylaxis: a prospective cohort study.
    Wu Q; Liu J; Wang Y; Zhou Q; Wang X; Xuan Z; Zhang L; Gao Y; Chen B; Hu Y
    Clin Microbiol Infect; 2019 Jul; 25(7):872-877. PubMed ID: 30472425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological characteristics of breakthrough varicella infection during varicella outbreaks in Shanghai, 2008-2014.
    Zhu YF; Li YF; DU Y; Zeng M
    Epidemiol Infect; 2017 Jul; 145(10):2129-2136. PubMed ID: 28446261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of post-exposure prophylaxis during varicella outbreaks among primary and middle school students in Shanghai: An analysis of three-year surveillance data.
    Cao Z; Chen D; Yang Y; Zhang D
    Vaccine; 2018 Sep; 36(38):5754-5759. PubMed ID: 30111515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varicella-zoster virus infections in pregnancy.
    Sauerbrei A
    Intervirology; 1998; 41(4-5):191-6. PubMed ID: 10213895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management and outcome of a varicella exposure in a neonatal intensive care unit: lessons for the vaccine era.
    Kellie SM; Makvandi M; Muller ML
    Am J Infect Control; 2011 Dec; 39(10):844-8. PubMed ID: 21600672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THE changing seroepidemiology of varicella in Japan: 1977-1981 and 2001-2005.
    Ueno-Yamamoto K; Tanaka-Taya K; Satoh H; Araki K; Kaku M; Okabe N
    Pediatr Infect Dis J; 2010 Jul; 29(7):667-9. PubMed ID: 20228693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of One-dose Varicella Vaccination on Disease Severity in Children during Outbreaks in Seoul, Korea.
    Lee YH; Choe YJ; Cho SI; Park H; Bang JH; Lee JK
    J Korean Med Sci; 2019 Mar; 34(10):e83. PubMed ID: 30886550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outbreak of varicella in a highly vaccinated preschool population.
    Fu J; Wang J; Jiang C; Shi R; Ma T
    Int J Infect Dis; 2015 Aug; 37():14-8. PubMed ID: 26072038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.